Working… Menu

Study of Trofinetide for the Treatment of Girls and Women With Rett Syndrome (LAVENDER™)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04181723
Recruitment Status : Active, not recruiting
First Posted : November 29, 2019
Last Update Posted : August 16, 2021
Information provided by (Responsible Party):
ACADIA Pharmaceuticals Inc.

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : September 2021
Estimated Study Completion Date : October 2021